15 Best Hospitals for Cancer Treatment in the US

Published on February 16, 2024 at 3:10 am by Laiba Immad in Lists, News

In this article, we will be taking a look at the 15 best hospitals for cancer treatment in the US. If you are not interested in reading about the global cancer care market, head straight to the 5 Best Hospitals For Cancer Treatment In The US.

When battling cancer, choosing the right hospital for treatment is paramount. In the United States, several medical institutions stand out for their excellence in cancer care, offering cutting-edge treatments, compassionate care, and a multidisciplinary approach to tackling this complex disease. From renowned research facilities to top-ranked hospitals like University of Texas MD Anderson, Cleveland Clinic, and Mayo Clinic Rochester, the landscape is rich with options for patients seeking the best care possible.

Global Cancer Treatment Market Growth, Key Players, and Financial Toxicity

The global cancer treatment market is experiencing significant growth, with projections indicating a robust CAGR of 9.20% by 2032, reaching approximately US$393.61 billion. Leading players such as F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, and AbbVie, Inc. are instrumental in shaping this dynamic landscape. Market segmentation by application, end user, and top-selling drugs like Ibrance, Avastin, and Alimta, among others underscores diverse avenues for expansion.

Innovative cancer treatment modalities, including molecular and immune therapies, targeted agents, and advanced diagnostic technologies, are driving advancements globally. However, the rising costs associated with these treatments are leading to increased financial toxicity for cancer patients, impacting their well-being and quality of life.

Financial statistics reveal that cancer patients bear a significant burden of out-of-pocket expenses, spending a median of $1,730–$4,727 annually. This expenditure exceeds that of patients without cancer by an estimated $976–$1,170.

Studies indicate that between 22 and 64 percent of cancer patients experience stress or worry about medical bill payments. Additionally, rising cancer care costs contribute to increased financial distress, particularly affecting low-income and uninsured patients.

Revolutionizing Cancer Care Through Advanced Technologies

Integrating artificial intelligence (AI) and other cutting-edge technologies revolutionizes cancer care. AI is used to grade and classify cancer, improve diagnostics, reduce screening costs, and discover new drugs. Additionally, telehealth, robotic surgery, and precision medicine are transforming cancer care delivery. The Global Oncology Trends report highlights the increasing use of novel cancer medicines and immunology in transforming cancer treatment.

The use of AI in cancer care is expected to reshape the existing scenario, potentially reducing screening costs, providing more reliable diagnostics, improving prognostics, and aiding in discovering new drugs. However, the widespread adoption of AI in cancer care faces challenges such as ethical and regulatory issues, difficulty in incorporation into clinical practice, and lack of standardization.

As of 2020, there were an estimated 19.3 million new cancer cases and 10 million cancer-related deaths worldwide. In the United States, around 1.9 million new cancer cases were diagnosed in 2022, with approximately 609,360 cancer-related deaths. The types of cancer with the highest death rates globally include lung, colorectal, stomach, liver, and breast cancer.

Financial statistics reveal that cancer medicine spending rose to $185 billion globally in 2021, with a significant portion focused on major developed markets such as the United States, EU4+UK, and Japan. Adopting breakthrough medicines and diagnostics improves outcomes for millions worldwide, although broad and equitable access remains a significant challenge.

Leading Cancer Treatment Companies

Pfizer Inc. (NYSE: PFE), Merck & Co., Inc. (NYSE: MRK), Bristol Myers Squibb (NYSE: BMY), and Guardant Health (NASDAQ: GH) are prominent players in the cancer treatment industry. These companies are driving innovation and have significant market capitalization.

Pfizer Inc. (NYSE:PFE) recently acquired Seagen Inc., doubling its Oncology pipeline and strengthening its position in cancer treatment. The company’s financial commitment to this acquisition, approximately $43 billion, reflects its dedication to advancing cancer care. Pfizer Inc. (NYSE:PFE) collaboration with the American Cancer Society through the “Change the Odds” initiative demonstrates its efforts to address cancer care disparities.

Merck & Co., Inc. (NYSE:MRK) is known for Keytruda (pembrolizumab), which has multiple FDA approvals, including cervical and lung cancer treatments. Despite setbacks in specific trials, Merck & Co., Inc, (NYSE:MRK) continues to explore innovative cancer treatments, such as personalized mRNA cancer therapy, in collaboration with Moderna.

Guardant Health, Inc. (NASDAQ:GH) specializes in precision oncology through advanced blood tests like Guardant Reveal and Guardant360, offering insights into disease recurrence and treatment response. Guardant Health, Inc. (NASDAQ:GH)’s strategic partnerships, such as with Hikma, aim to expand access to these tests globally, enhancing cancer care on a broader scale.

These companies exemplify the forefront of cancer treatment, driving research, innovation, and accessibility in the fight against cancer.

A hand holding cancer cells with a magnifying glass, highlighting the company’s target of curing diseases.

Our Methodology

Our methodology for identifying the Best Hospitals for Cancer Treatment in the US involved conducting thorough research using sources like US News, News Week, Beckers Hospital Review, The Healthy, and Wtop, and five other sources. We also scoured through related reddit threads and gathered consensus from there as well. We selected the top hospitals for cancer treatment in the US using a structured scoring system. Each cancer hospital received a score of 0.5 every time it appeared in our consensus research. We summed up these scores based on the frequency of apparence. We assigned additional scores for tiebreaking if two hospitals appeared the same number of times in our research, by seeing which ones of those were outranking others in our research sources. By employing this approach, we created a definitive compilation of the Best Hospitals for Cancer Treatment in the US and ranked them in ascending scores.

Here is our list of the best hospitals for cancer treatment in the US.

15. Northwestern Medicine-Northwestern Memorial Hospital

Total Score: 2

Affiliated with Lurie Cancer Center, Northwestern Memorial Hospital ranks 15th for being one of the best hospitals for cancer treatments , treating over 18,000 new patients annually. Lurie Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, serves nearly 16,000 new patients yearly. With a dedicated team of specialists, including medical, surgical, and radiation oncologists, Northwestern Memorial Hospital offers individualized care, innovative treatments, and state-of-the-art clinical trials.

14. UT Southwestern Medical Center

Total Score: 2

The UT Southwestern Medical Center, notably the Harold C. Simmons Comprehensive Cancer Center, is a leading institution for cancer treatment and research in the US. Designated by the National Cancer Institute as a Comprehensive Cancer Center, it is recognized for exceptional patient care, innovative therapies, and leading-edge clinical trials. The center supports 13 multidisciplinary teams and has 274 members, including distinguished experts. It has received substantial funding for cancer research and prevention initiatives, with over $315 million from the Cancer Prevention and Research Institute of Texas since 2010.

13. Houston Methodist Hospital

Total Score: 2.5

Houston Methodist Hospital is one of the best hospitals for cancer treatment in the US, with over 100 expert oncologists, surgeons, and specialists. Although the exact number of cancer patients treated isn’t provided, its high patient volume is evident from 138,162 admissions and 1.92 million outpatient visits. Houston Methodist Hospital is a large nonprofit healthcare organization with eight hospitals, 2,646 operating beds, and 29,730 employees. The hospital’s commitment to cancer research and treatment is evident in its $202 million annual research expenditures.

12. University Of Chicago Medical Center

Total Score: 3

The University of Chicago Medical Center is a leading institution for cancer treatment in the US, having treated 4,022 cancer patients in 2020, including malignancies and benign central nervous system neoplasms. With over 200 cancer researchers and physicians, it is one of only 71 hospitals in the US designated by the National Cancer Institute (NCI) for delivering cutting-edge cancer care to its communities.

11. USC Norris Cancer Hospital Keck Medical Center Of USC

Total Score: 3

The USC Norris Comprehensive Cancer Center, part of the Keck Medical Center of USC, is a leading hospital for cancer treatment in the US, designated by the National Cancer Institute. With a focus on 13 critical areas of cancer treatment, it boasts over 250 dedicated physicians and scientists. Nationally ranked number 1 in adult specialty and rated high-performing in 4 adult procedures, its quality rankings underscore its expertise in cancer care.

10. Cedars Sinai Medical

Total Score: 4

Cedars-Sinai Medical Center is a renowned hospital for cancer treatment in the US, treating patients with over 60 types of cancer in 2022. While the exact count of cancer specialists isn’t provided, the hospital is committed to training emerging researchers and mentoring early-career investigators at top institutions nationwide.

9. Mount Sinai

Total Score: 4.5

Mount Sinai Medical Center, part of the Mount Sinai Health System, is a top US hospital for cancer treatment, offering comprehensive care for various cancer types. With a multidisciplinary approach and integration of research from The Tisch Cancer Institute, it provides personalized care from diagnosis to post-treatment. Their team of specialists includes medical oncologists, surgeons, and palliative care experts. The system generates an annual revenue of $11.3 billion.

8. Stanford Health Care Stanford Hospital

Total Score: 4.5

Stanford Health Care and Stanford Hospital are renowned for their exceptional cancer treatment, backed by the Stanford Cancer Institute (SCI), a National Cancer Institute-designated Comprehensive Cancer Center. With over 450 members collaborating across disciplines, SCI translates research into improved treatments. Stanford Medicine Cancer Center is the sole NCI-Designated Comprehensive Cancer Center between San Francisco and Los Angeles. The Stanford Cancer Institute boasts over 400 dedicated faculty members specializing in cancer care and research.

7. Cleveland Clinic

Total Score: 5

The Cleveland Clinic’s Taussig Cancer Institute stands seventh among the best hospitals for cancer treatment in the US, serving thousands of patients annually. In 2021 alone, they provided 459,175 visits, offering comprehensive care through a multidisciplinary team of over 700 professionals. Their Breast Cancer Program emphasizes prevention, detection, and treatment, with standardized care pathways and tumor board reviews across multiple locations. The clinic maintains high performance in quality measures for treatments for breast cancer which is one of the deadliest and most common cancers in the world, ensuring excellent care standards.

6. Johns Hopkins Hospital

Total Score: 5.5

Johns Hopkins Hospital houses the Sidney Kimmel Comprehensive Cancer Center is a top cancer treatment hospital in the US. With 35 departments and five schools at Johns Hopkins University, the center focuses on cutting-edge basic, translational, and clinical research to enhance patient care. It prioritizes understanding cancer mechanisms, drug development, quantitative approaches, and improving care, notably establishing a Convergence Institute to ensure research benefits all, including underserved populations. Recent developments include a $35 million gift to study cancer metastasis, leading to the Giovanis Institute for Translational Cell Biology establishment.

Click to see and continue reading the 5 Best Hospitals For Cancer Treatment in the US.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

The AI infrastructure supercycle
The onshoring boom driven by Trump-era tariffs
A surge in U.S. LNG exports
And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

Access to our Detailed Report on our AI, Tariffs, and Nuclear Energy Stock with 100+% potential upside within 12 to 24 months
BONUS REPORT on our #1 AI-Robotics Stock with 10000% upside potential: Our in-depth report dives deep into our #1 AI/robotics stock’s groundbreaking technology and massive growth potential.
One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
Bonus Content: Premium access to members-only fund manager video interviews
Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.
30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up

15 Best Hospitals for Cancer Treatment in the US

Published on February 16, 2024 at 3:10 am by Laiba Immad in Lists, News

Global Cancer Treatment Market Growth, Key Players, and Financial Toxicity

Revolutionizing Cancer Care Through Advanced Technologies

Leading Cancer Treatment Companies

Our Methodology

15. Northwestern Medicine-Northwestern Memorial Hospital

14. UT Southwestern Medical Center

13. Houston Methodist Hospital

12. University Of Chicago Medical Center

11. USC Norris Cancer Hospital Keck Medical Center Of USC

10. Cedars Sinai Medical

9. Mount Sinai

8. Stanford Health Care Stanford Hospital

7. Cleveland Clinic

6. Johns Hopkins Hospital

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up:

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Premium

Log In

Sign Up

15 Best Hospitals for Cancer Treatment in the US

Published on February 16, 2024 at 3:10 am by Laiba Immad in Lists, News

Share

Global Cancer Treatment Market Growth, Key Players, and Financial Toxicity

Revolutionizing Cancer Care Through Advanced Technologies

Leading Cancer Treatment Companies

Our Methodology

15. Northwestern Medicine-Northwestern Memorial Hospital

14. UT Southwestern Medical Center

13. Houston Methodist Hospital

12. University Of Chicago Medical Center

11. USC Norris Cancer Hospital Keck Medical Center Of USC

10. Cedars Sinai Medical

9. Mount Sinai

8. Stanford Health Care Stanford Hospital

7. Cleveland Clinic

6. Johns Hopkins Hospital

Share

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on October 6, 2025 at by Inan Dogan, PhD

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Published on October 5, 2025 at by Inan Dogan, PhD

Here’s why this is a deal you can’t afford to pass up: